Triveni Bio Funding: $277M Raised, Series C (2026)
Triveni Bio is a Biotech company based in Watertown, Massachusetts. It has raised $277M in total funding. Latest round: Series C.
Triveni Bio funding overview
Triveni Bio is a Biotech company based in Watertown, Massachusetts. Triveni Bio has raised $277M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2026. The round record for Triveni Bio runs through 2026; nothing later has been disclosed. Investors on record include Ascenta Capital, Janus Henderson Investors, Deep Track Capital, Goldman Sachs Alternatives, Atlas Venture, Cormorant Asset Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Triveni Bio has raised $277M in total disclosed funding across the rounds on record.
Who has invested in Triveni Bio?
Ascenta Capital, Janus Henderson Investors, Deep Track Capital, Goldman Sachs Alternatives, Atlas Venture, Cormorant Asset Management are named among the investors backing Triveni Bio.
What was the latest Triveni Bio funding round?
The most recent disclosed round is a Series C, announced in June 2026.
Where is Triveni Bio based?
Triveni Bio is based in Watertown, Massachusetts.
What sector does Triveni Bio operate in?
Triveni Bio is tracked under Biotech from Watertown, Massachusetts, with $277M in disclosed funding.
When did Triveni Bio last raise?
The last disclosed Triveni Bio round closed in June 2026 at Series C.
Round data for Triveni Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Watertown and backer lists below.
